Marshall, Shoko
Wakatsuki, Takeru
Takahari, Daisuke
Matsushima, Tomohiro
Ishizuka, Naoki
Nakayama, Izuma
Osumi, Hiroki
Ogura, Mariko
Ichimura, Takashi
Shinozaki, Eiji
Chin, Keisho
Yamaguchi, Kensei
Article History
Accepted: 19 February 2022
First Online: 18 April 2022
Declarations
:
: This study was approved by the Cancer Institute Hospital of the Japanese Foundation for Cancer Research Institutional Review Board (2017-1044). The study followed the Declaration of Helsinki by the World Medical Association. Written informed consent was obtained from all study participants.
: Not applicable
: Shoko Marshall, Takeru Wakatsuki, Tomohiro Matsushima, Naoki Ishizuka, Izuma Nakayama, Hiroki Osumi, Mariko Ogura, Takashi Ichimura, Keisho Chin declare no competing interests. Daisuke Takahari reports lecture-related fees from Taiho, Eli Lilly, Bristol-Myers Squibb, Ono, and Chugai outside the submitted work. Eiji Shinozaki reports lecture-related fees from Chugai outside the submitted work. Kensei Yamaguchi reports legal fees from Chugai outside the submitted work.